Ozempic's new warning: GLP-1 weight loss drugs linked to rare vision loss
Ozempic’s new warning: GLP-1 weight loss drugs linked to rare vision lossThe U.S. Food and Drug Administration has announced that GLP-1 drugs used for weight loss and diabetes must carry warnings about a rare risk of vision loss.
The agency informed patients and healthcare...
0

0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.